Versant Capital Management
IDYA icon

Versant Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Versant Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$109K Buy
2,850
+25
+0.9% +$943 0.01% 885
2026
Q2 		$105K Buy
2,825
+596
+27% +$18.2K 0.01% 897
2026
Q1 		$74.3K Hold
2,229
– – 0.01% 1017
2025
Q4 		$77.1K Hold
2,229
– – 0.01% 873
2025
Q3 		$60.7K Buy
2,229
+168
+8% +$4.06K 0.01% 942
2025
Q2 		$43.3K Buy
2,061
+1,495
+264% +$28.7K 0.01% 1057
2025
Q1 		$9.27K Buy
+566
New +$12.1K ﹤0.01% 1757

Other funds holding IDYA

General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Versant Capital Management's IDYA Position: Q3 2026 in Review

Versant Capital Management increased its IDEAYA Biosciences (IDYA) stake by 0.88% in Q3 2026, buying an estimated $943 and bringing the position to 2,850 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #885.

Versant Capital Management first reported a position in IDYA in Q1 2025 and has held it in 7 quarters since. 62 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Versant Capital Management held 2,850 shares of IDEAYA Biosciences worth $109K as of Q3 2026.
  • Versant Capital Management bought 25 IDEAYA Biosciences shares in Q3 2026, an estimated $943.
  • IDEAYA Biosciences made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #885 holding.
  • Versant Capital Management first reported a position in IDEAYA Biosciences in Q1 2025 and has held it in 7 quarters since.
  • 62 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.